Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 
Year : 1999  |  Volume : 20  |  Issue : 1  |  Page : 16-19

Vancomycin resistant enterococci.

P.D. Hinduja National Hospital & Medical Research Centre, Mumbai 400 016, India

Correspondence Address:
MM Chandiwal
P.D. Hinduja National Hospital & Medical Research Centre, Mumbai 400 016, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Enterococcal isolates today are increasingly resistant to antibiotics and are also becoming common nosocomial pathogens. This double evolution is associated with extensive use of oral cephalosporins, aminoglycosides and quinolones, which have poor in vitro activity against this bacterial genus. This gives the enterococci, an inherent advantage over others in being selected out. We report the first isolate of vancomycin resistant enterococci (VRE) at our centre. Though our patient had no morbidity associated with VRE, it is necessary to prevent dissemination with proper barrier precautions and policy. Since there is no fully efficient therapy for infections due to glycopeptide resistant enterococci, efforts to limit the spread of these microorganisms are now considered essential.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal